What is the treatment for Grover's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Grover's Disease

For Grover's disease, first-line treatment consists of topical corticosteroids (such as betamethasone or mometasone furoate 0.1% cream) applied twice daily for 3-4 weeks, with topical vitamin D analogues as an alternative or adjunctive option. 1, 2

Initial Management Strategy

  • Apply mid-to-high potency topical corticosteroids (betamethasone or mometasone furoate 0.1% cream) twice daily for 3-4 weeks as the primary treatment approach 1, 3, 2
  • Add oral antihistamines for symptomatic relief of pruritus as adjuvant therapy 2
  • Topical vitamin D analogues can be used as first-line alternatives or in combination with corticosteroids 2, 4

Conservative Measures and Trigger Avoidance

  • Avoid excessive heat, sweating, and occlusive environments (such as tight bandages or prolonged bedrest) which can precipitate or exacerbate the condition 3, 2, 4
  • Minimize ultraviolet radiation exposure, as UV light has been identified as an exacerbating factor 1
  • Apply moisturizing emollients regularly, particularly in cool, dry conditions which may trigger disease onset 2
  • Note that the disease is four times more likely to be diagnosed in winter months, suggesting xerosis cutis as a contributing factor 1

Escalation for Refractory or Severe Cases

When first-line topical therapy fails after 3-4 weeks or in cases of extensive disease:

  • Oral retinoids (isotretinoin or acitretin) are effective for refractory cases, with three of four patients in one series achieving remissions lasting up to 10 months 5, 4
  • Systemic corticosteroids can be considered for severe, widespread eruptions 2
  • PUVA phototherapy has demonstrated efficacy in suppressing symptoms 2, 4
  • Methotrexate is reserved for resistant cases that fail other systemic therapies 2

Clinical Course and Prognosis

  • The disease typically follows a transient course lasting only a few weeks with appropriate treatment 1, 3
  • However, chronic cases can persist for months to years, particularly in patients on hemodialysis or with immunosuppression 1, 2
  • Spontaneous resolution may occur even without treatment, especially when precipitating factors are removed 1, 2

Important Caveats

  • In immunosuppressed patients (kidney transplant recipients, HIV, bone marrow transplant), the disease may have a more prolonged course despite treatment 1
  • Renal transplantation has been associated with remission in some hemodialysis patients with Grover's disease, though the mechanism remains unclear 1
  • The condition can recur after initial successful treatment, particularly if triggering factors persist 5
  • Histological confirmation is essential for diagnosis, showing characteristic suprabasal acantholysis with dyskeratosis 1, 3

References

Research

Grover's Disease in a Kidney Transplant Recipient.

Acta dermatovenerologica Croatica : ADC, 2019

Research

Grover disease: review of subtypes with a focus on management options.

International journal of dermatology, 2020

Research

Monolateral Grover's Disease with Blaschkoid Distribution.

Acta dermatovenerologica Croatica : ADC, 2017

Research

Grover's disease: 34 years on.

The Australasian journal of dermatology, 2004

Research

Grover's disease treated with isotretinoin. Report of four cases.

Journal of the American Academy of Dermatology, 1985

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.